黒肺病の世界市場レポート 2024年

黒肺病の市場規模は近年急速に拡大しています。2023年の84億4,000万米ドルから2024年には96億6,000万米ドルへとCAGR14.5％で拡大します。歴史的な期間における成長は、石炭採掘産業の成長、認識と教育、報酬と福利厚生、法律と法的発展に起因しています。

黒肺病市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR14.7％で167億米ドルに成長します。予測期間の成長は、公衆衛生への取り組み、医療の進歩、治療選択肢の増加、擁護・支援団体に起因すると考えられます。予測期間の主な動向には、高度な診断技術、調査と予防、ヘルスケアへのアクセス、技術の進歩などがあります。

黒肺病市場の成長は、鉱業活動の拡大によって促進されると予測されます。これらの事業では、地殻から貴重な鉱物、鉱石、地質材料を抽出します。黒肺病は、炭鉱労働者が罹患する疾患で、有害な炭素含有粒子を含む炭鉱ダストの吸入に起因します。例えば、2022年1月、米国地質調査所は、2021年の世界の銀鉱山生産量がわずかに増加し、2020年の2万3,500トンから推定2万4,000トンに増加したと報告しました。これは、採掘活動の継続的な拡大を指し示しています。その結果、採掘活動の増加は黒肺病市場の成長の主要な促進要因となっています。

結核の有病率の上昇は、黒肺病市場の成長を促進すると予測されています。結核は主に結核菌によって引き起こされ、感染者が咳やくしゃみをすることで感染する空気感染性の細菌感染症です。咳、発熱、体重減少、倦怠感などの症状が現れます。結核患者は黒肺病を発症するリスクが高く、石炭粉塵にさらされる可能性が高いため、結核の罹患率の増加は黒肺病の成長に関連しています。例えば、2023年3月、米国疾病予防管理センターは、2022年の米国における結核患者数を8,300人と報告し、2021年の7,874人から増加しました。このように、結核の有病率の上昇は、黒肺病市場の成長を支える重要な要因となっています。

2023年の黒肺病市場では北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。黒肺病レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の黒肺病市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 単純性炭坑夫塵肺症
• 複雑性炭坑夫塵肺症
• その他のタイプ
• 世界の黒肺病市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 酸素療法
• 気管支拡張薬
• 肺移植
• 幹細胞療法
• その他の治療
• 世界の黒肺病市場、診断別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 生検
• イメージング
• 完全な血球数
• 肺または肺機能検査
• 身体検査
• その他の診断
• 世界の黒肺病市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院と診療所
• 研究機関および学術機関
• 診断センターと研究所
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の黒肺病市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の黒肺病市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 黒肺病市場の競合情勢
• 黒肺病市場の企業プロファイル
  • Pfizer Inc.
  • Johnson and Johnson
  • Siemens AG
  • General Electric
  • F. Hoffmann-La Roche AG

第31章 その他の主要および革新的な企業

• Merck and Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• AstraZeneca plc
• Melinta Therapeutics LLC
• GlaxoSmithKline plc
• Medtronic plc
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Toshiba Corporation
• Koninklijke Philps N.V.
• Mayo Clinic
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

“Black Lung Disease Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on black lung disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for black lung disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The black lung disease market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Simple Coal Worker's Pneumoconiosis; Complicated Coal Worker's Pneumoconiosis; Other Types
• 2) By Treatment: Oxygen Therapy; Bronchodilators; Lung Transplant; Stem Cell Therapy; Other Treatment
• 3) By Diagnosis: Biopsy; Imaging; Full Blood Count; Pulmonary Or Lung Function Tests; Physical Examination; Other Diagnosis
• 4) By End Users: Hospitals And Clinics; Research Organizations And Academic Institutes; Diagnostic Centers And Labs; Other End Users
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson; Siemens AG; General Electric; F. Hoffmann-La Roche AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Black lung disease, also known as coal workers' pneumoconiosis (CWP), is a chronic and potentially fatal lung condition primarily affecting coal miners and those exposed to coal dust. This ailment is characterized by the accumulation of coal dust particles in the lungs, leading to inflammation, scarring, and damage to lung tissues.

The disease is categorized into simple coal workers' pneumoconiosis, complicated coal workers' pneumoconiosis, and other forms. Simple CWP, often referred to as simple black lung disease, arises from prolonged exposure to coal dust. Treatment options encompass oxygen therapy, bronchodilators, lung transplant, stem cell therapy, and other interventions. Diagnosing the condition involves procedures like biopsy, various imaging techniques, full blood count analysis, pulmonary function tests, physical examination, among others. These diagnostic and treatment approaches are employed across a range of healthcare settings, including hospitals, clinics, research institutions, diagnostic centers, and laboratories.

The black lung disease market research report is one of a series of new reports from The Business Research Company that provides black lung disease market statistics, including black lung disease industry global market size, regional shares, competitors with a black lung disease market share, detailed black lung disease market segments, market trends and opportunities and any further data you may need to thrive in the black lung disease industry. This black lung disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The black lung disease market size has grown rapidly in recent years. It will grow from $8.44 billion in 2023 to $9.66 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to coal mining industry growth, awareness and education, compensation and benefits, legislative and legal developments.

The black lung disease market size is expected to see rapid growth in the next few years. It will grow to $16.7 billion in 2028 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to public health initiatives, medical advancements, increasing treatment options, advocacy and support organizations. Major trends in the forecast period include advanced diagnostic techniques, research and prevention, healthcare access, technological advancements.

The growth of the black lung disease market is anticipated to be fueled by the expanding mining activities. These operations involve the extraction of valuable minerals, ores, and geological materials from the Earth's crust. Black lung disease, a condition affecting coal miners, is attributed to the inhalation of coal mine dust, which contains hazardous carbon-containing particles. For instance, in January 2022, the United States Geological Survey reported a slight increase in global silver mine production in 2021, rising from 23,500 tons in 2020 to an estimated 24,000 tons. This points to the ongoing expansion of mining activities. Consequently, the rise in mining endeavors is a key driver for the growth of the black lung disease market.

The escalating prevalence of tuberculosis is anticipated to drive the growth of the black lung disease market. Tuberculosis, caused primarily by Mycobacterium tuberculosis, is an airborne bacterial infection transmitted when an infected person coughs or sneezes. It manifests with symptoms like coughing, fever, weight loss, and fatigue. The increasing incidence of tuberculosis is linked to the growth of black lung disease, as individuals with TB face a higher risk of developing black lung disease and are more likely to be exposed to coal dust. For instance, in March 2023, the Centers for Disease Control and Prevention reported 8,300 cases of tuberculosis in the US in 2022, up from 7,874 cases in 2021. Thus, the rising prevalence of tuberculosis is a significant driver behind the growth of the black lung disease market.

A notable hindrance to the growth of the black lung disease market is the prevailing lack of awareness about the disease. This is particularly significant among miners and their families. One primary reason for this challenge is the prolonged development of the disease, which makes early diagnosis a difficult task. For instance, as of December 2021, Wolfe Williams & Reynolds P.C., a US-based social security disability firm, underlined this issue, emphasizing the limited understanding of black lung disease and its associated symptoms, resulting in delayed diagnosis and treatment. Consequently, the existing lack of awareness concerning the disease stands as a substantial barrier to the market's growth.

The growth of the black lung disease market is significantly bolstered by government funding initiatives. These initiatives involve the allocation of financial resources by government bodies, often at federal, state, or local levels, to support a range of activities, programs, projects, and organizations that serve public interests or fulfill specific government objectives. One crucial area of focus for such funding is the protection of coal miners from black lung disease. For instance, in September 2022, according to the US Department of Labor Blog, a US-based government authority, funding for miners with black lung disease was permanently extended with the Inflation Reduction Act of 2022. This act has provided essential and permanent funding for miners and their families affected by black lung disease, ensuring federal black lung benefits. As a result, government funding initiatives play a pivotal role in driving both the black lung disease market and the welfare of miners.

In June 2022, Bristol Myers Squibb, a prominent US-based pharmaceutical company, successfully acquired Turning Point Therapeutics, further solidifying its position in the field of oncology and black lung disease treatment. This strategic move allows Bristol Myers to integrate a cutting-edge, late-stage precision oncology asset into its already robust oncology portfolio. Turning Point Therapeutics, a US-based pharmaceutical company, is currently in the process of developing a drug with potential applications in the treatment of black lung disease.

Major players in the black lung disease market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Melinta Therapeutics LLC, GlaxoSmithKline PLC, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Toshiba Corporation, Koninklijke Philps N.V., Mayo Clinic, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Lab India Pvt. Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Lupin Limited .

North America was the largest region in the black lung disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the black lung disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The black lung disease market includes revenues earned by entities by providing pulmonary rehabilitation (PR), medical services and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Black Lung Disease Market Characteristics

3. Black Lung Disease Market Trends And Strategies

4. Black Lung Disease Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Black Lung Disease Market Size and Growth

• 5.1. Global Black Lung Disease Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Black Lung Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Black Lung Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Black Lung Disease Market Segmentation

• 6.1. Global Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Simple Coal Worker's Pneumoconiosis
• Complicated Coal Worker's Pneumoconiosis
• Other Types
• 6.2. Global Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oxygen Therapy
• Bronchodilators
• Lung Transplant
• Stem Cell Therapy
• Other Treatment
• 6.3. Global Black Lung Disease Market, Segmentation By Diagnosis , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Biopsy
• Imaging
• Full Blood Count
• Pulmonary Or Lung Function Tests
• Physical Examination
• Other Diagnosis
• 6.4. Global Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Research Organizations And Academic Institutes
• Diagnostic Centers And Labs
• Other End Users

7. Black Lung Disease Market Regional And Country Analysis

• 7.1. Global Black Lung Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Black Lung Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Black Lung Disease Market

• 8.1. Asia-Pacific Black Lung Disease Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Black Lung Disease Market

• 9.1. China Black Lung Disease Market Overview
• 9.2. China Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Black Lung Disease Market

• 10.1. India Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Black Lung Disease Market

• 11.1. Japan Black Lung Disease Market Overview
• 11.2. Japan Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Black Lung Disease Market

• 12.1. Australia Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Black Lung Disease Market

• 13.1. Indonesia Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Black Lung Disease Market

• 14.1. South Korea Black Lung Disease Market Overview
• 14.2. South Korea Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Black Lung Disease Market

• 15.1. Western Europe Black Lung Disease Market Overview
• 15.2. Western Europe Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Black Lung Disease Market

• 16.1. UK Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Black Lung Disease Market

• 17.1. Germany Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Black Lung Disease Market

• 18.1. France Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Black Lung Disease Market

• 19.1. Italy Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Black Lung Disease Market

• 20.1. Spain Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Black Lung Disease Market

• 21.1. Eastern Europe Black Lung Disease Market Overview
• 21.2. Eastern Europe Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Black Lung Disease Market

• 22.1. Russia Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Black Lung Disease Market

• 23.1. North America Black Lung Disease Market Overview
• 23.2. North America Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Black Lung Disease Market

• 24.1. USA Black Lung Disease Market Overview
• 24.2. USA Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Black Lung Disease Market

• 25.1. Canada Black Lung Disease Market Overview
• 25.2. Canada Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Black Lung Disease Market

• 26.1. South America Black Lung Disease Market Overview
• 26.2. South America Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Black Lung Disease Market

• 27.1. Brazil Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Black Lung Disease Market

• 28.1. Middle East Black Lung Disease Market Overview
• 28.2. Middle East Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Black Lung Disease Market

• 29.1. Africa Black Lung Disease Market Overview
• 29.2. Africa Black Lung Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Black Lung Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Black Lung Disease Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Black Lung Disease Market Competitive Landscape And Company Profiles

• 30.1. Black Lung Disease Market Competitive Landscape
• 30.2. Black Lung Disease Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson and Johnson
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Siemens AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. General Electric
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. F. Hoffmann-La Roche AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Black Lung Disease Market Other Major And Innovative Companies

• 31.1. Merck and Co. Inc.
• 31.2. Bayer AG
• 31.3. Novartis AG
• 31.4. Sanofi S.A.
• 31.5. AstraZeneca plc
• 31.6. Melinta Therapeutics LLC
• 31.7. GlaxoSmithKline plc
• 31.8. Medtronic plc
• 31.9. Eli Lilly and Company
• 31.10. Boehringer Ingelheim International GmbH
• 31.11. Toshiba Corporation
• 31.12. Koninklijke Philps N.V.
• 31.13. Mayo Clinic
• 31.14. Baxter International Inc.
• 31.15. Teva Pharmaceutical Industries Ltd.

32. Global Black Lung Disease Market Competitive Benchmarking

33. Global Black Lung Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Black Lung Disease Market

35. Black Lung Disease Market Future Outlook and Potential Analysis

• 35.1 Black Lung Disease Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Black Lung Disease Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Black Lung Disease Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer